GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (ASX:SIG) » Definitions » Other Operating Expense

Sigma Healthcare (ASX:SIG) Other Operating Expense : A$28 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sigma Healthcare Other Operating Expense?

Sigma Healthcare's Other Operating Expense for the six months ended in Jan. 2024 was A$14 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2024 was A$28 Mil.

Sigma Healthcare's quarterly Other Operating Expense declined from Jan. 2023 (A$17 Mil) to Jul. 2023 (A$14 Mil) and declined from Jul. 2023 (A$14 Mil) to Jan. 2024 (A$14 Mil).

Sigma Healthcare's annual Other Operating Expense increased from Jan. 2022 (A$28 Mil) to Jan. 2023 (A$37 Mil) but then declined from Jan. 2023 (A$37 Mil) to Jan. 2024 (A$28 Mil).


Sigma Healthcare Other Operating Expense Historical Data

The historical data trend for Sigma Healthcare's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Other Operating Expense Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.26 30.99 27.69 36.82 28.32

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.35 20.14 16.68 14.33 14.00

Sigma Healthcare Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (ASX:SIG) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.